EFFECTS OF BETA(2)-AGONISTS AND BUDESONIDE ON INTERLEUKIN-1-BETA AND LEUKOTRIENE B-4 SECRETION - STUDIES OF HUMAN MONOCYTES AND ALVEOLAR MACROPHAGES

Citation
A. Zetterlund et al., EFFECTS OF BETA(2)-AGONISTS AND BUDESONIDE ON INTERLEUKIN-1-BETA AND LEUKOTRIENE B-4 SECRETION - STUDIES OF HUMAN MONOCYTES AND ALVEOLAR MACROPHAGES, The Journal of asthma, 35(7), 1998, pp. 565-573
Citations number
34
Categorie Soggetti
Respiratory System",Allergy
Journal title
ISSN journal
02770903
Volume
35
Issue
7
Year of publication
1998
Pages
565 - 573
Database
ISI
SICI code
0277-0903(1998)35:7<565:EOBABO>2.0.ZU;2-W
Abstract
The aims of the present study were to determine whether beta(2)-agonis ts (short- and long-acting) and a glucocorticoid (budesonide) influenc e the secretion of a pro-inflammatory cytokine (interleukin-1, [IL-1]) and a granulocyte attractant (leukotriene B-4 [LTB4]) and to compare these effects on blood monocyte and alveolar macrophages. Alveolar mac rophages (obtained by bronchoalveolar lavage) and blood monocytes from 26 healthy nonsmokers were stimulated with lipopolysaccharide or huma n serum opsonized zymosan. The influence of four beta(2)-agonists (sal butamol, terbutaline, formoterol, and salmeterol) and a corticosteroid (budesonide) on the release of interleukin-1 beta (IL-1 beta) and LTB 4 was studied in a dose-response manner (10(-8)-10(-5) mol/L for beta( 2)-agonists and 10(-10)-10(-6) mol/L for budesonide). The stimulated I L-1 beta secretion was significantly greater in blood monocytes than i n alveolar macrophages (p < 0.05), but alveolar macrophages were much more capable of secreting LTB4 than were blood monocytes (p < 0.001). Budesonide significantly inhibited the release of IL-1 beta from blood monocytes (p < 0.001), but no such effect was observed in alveolar ma crophages. Budesonide did not influence the release of LTB4 in either cell type. The beta(2)-agonists neither influenced the LTB4 nor the IL -beta secretion in either cell type with the exception of formoterol, which stimulated IL-1 beta secretion at the highest concentration (10( -5) mol/L, p<0.05). In conclusion, beta(2)-agonists exhibited only min or effects on IL-1 beta secretion from blood monocytes and no effect o n LTB4-secretion from either cell type, and budesonide effectively inh ibited the IL-1 beta release in blood monocytes, but not in alveolar m acrophages. Thus, induced secretion of LTB4 and IL-1 beta, and the sen sitivity to corticosteroids with regard to IL-1 beta secretion, change during the transformation from blood monocytes to alveolar macrophage s.